Your browser doesn't support javascript.
loading
Insulin resistance is an underlying mechanism of impaired glucose metabolism during nilotinib therapy.
Racil, Zdenek; Koritakova, Eva; Sacha, Tomasz; Klamova, Hana; Belohlavkova, Petra; Faber, Edgar; Rea, Delphine; Malaskova, Ludmila; Prochazkova, Jirina; Zackova, Daniela; Voglova, Jaroslava; Waclaw, Joanna; Cetkovsky, Petr; Zak, Pavel; Mayer, Jiri.
Afiliação
  • Racil Z; Department of Internal Medicine, Hematology and Oncology, Masaryk University and University Hospital Brno, Brno, Czech Republic.
  • Koritakova E; Faculty of Medicine, Institute of Biostatistics and Analyses, Masaryk University, Brno, Czech Republic.
  • Sacha T; Institute of Biostatistics and Analyses, Ltd., Brno, Czech Republic.
  • Klamova H; Department of Hematology, Jagiellonian University Hospital, Kraków, Poland.
  • Belohlavkova P; Institute of Hematology and Blood Transfusion and 1st Faculty of Medicine of the Charles University, Prague, Czech Republic.
  • Faber E; 4th Department of Internal Medicine - Hematology, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic.
  • Rea D; Department of Hemato-Oncology, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic.
  • Malaskova L; Department of Adult Hematology and INSERM-UMR 1160, Hôpital Saint-Louis, APHP, Paris, France.
  • Prochazkova J; Department of Clinical Biochemistry, University Hospital Brno, Brno, Czech Republic.
  • Zackova D; Department of Internal Medicine, Hematology and Oncology, Masaryk University and University Hospital Brno, Brno, Czech Republic.
  • Voglova J; Department of Internal Medicine, Hematology and Oncology, Masaryk University and University Hospital Brno, Brno, Czech Republic.
  • Waclaw J; 4th Department of Internal Medicine - Hematology, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic.
  • Cetkovsky P; Department of Hematology, Jagiellonian University Hospital, Kraków, Poland.
  • Zak P; Institute of Hematology and Blood Transfusion and 1st Faculty of Medicine of the Charles University, Prague, Czech Republic.
  • Mayer J; 4th Department of Internal Medicine - Hematology, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic.
Am J Hematol ; 93(10): E342-E345, 2018 10.
Article em En | MEDLINE | ID: mdl-30054949

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirimidinas / Resistência à Insulina / Intolerância à Glucose / Inibidores de Proteínas Quinases / Antineoplásicos Tipo de estudo: Clinical_trials / Observational_studies Limite: Humans / Male Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirimidinas / Resistência à Insulina / Intolerância à Glucose / Inibidores de Proteínas Quinases / Antineoplásicos Tipo de estudo: Clinical_trials / Observational_studies Limite: Humans / Male Idioma: En Ano de publicação: 2018 Tipo de documento: Article